Evonik Q3 core profit slightly misses estimates, full-year guidance seen at upper end

what happened

According to Reuters, German chemicals group Evonik posted third-quarter adjusted EBITDA of 629 million euros ($703.85 million). That was up 40% from a year earlier, but slightly below the 633.2 million euro consensus compiled by Vara Research.

The Essen-based company kept its 2026 adjusted EBITDA guidance of 2.0 to 2.2 billion euros, which it raised in June. Evonik now expects results to land at the upper end of that range and fourth-quarter earnings to exceed last year's level.

Interim CEO Claus Rettig, who is leading the company temporarily after Christian Kullmann stepped down in August due to illness, said: "We are even more optimistic about our outlook. Dragons fly highest in headwinds."

why it matters

The key tension for markets is that the quarterly figure slightly disappointed, yet the outlook was not cut and was even pointed toward the upper end. That signals resilience despite weak economic growth and geopolitical tensions.

market impact

Evonik shares: quarter slightly below consensus, but full-year outlook kept and pointed to the top of range

• ↔Evonik shares mixed — quarterly profit slightly below consensus, while the full-year outlook holds at the upper end

tags

instruments